ArgusEye

🚀 ArgusEye is of the five companies selected to participate in the BIO-X Accelerate Program! "BIO-X Accelerate will help us accelerate towards our goal of developing biosensors that can fundamentally reshape the biopharmaceutical industry. This support allows us to prioritize product development of a new product which will further allow us to offer solutions that cover the entire bioprocessing chain." — Nathalie Elsässer, COO

We’re thrilled to welcome Ana Pinheiro, to the ArgusEye team! Ana brings extensive experience in molecular and biochemical analysis, particularly in quality control within the pharmaceutical industry.   As our new Application Scientist, Ana will play a crucial role in helping our customers maximize the value of our innovative sensor systems.   Welcome to ArgusEye, Ana – we’re excited to have you with us! #welcome #team #expansion #innovation

Why is ArgusEye developing the Auga platform?💡 CEO Dr. Erik Martinsson answers in the video below! Learn more about the first product in the Auga platform AugaOne here: https://lnkd.in/dSvAwxYN #ArgusEye #AugaPlatform #BiopharmaInnovation #RealTimeData #DrugDevelopment #Innovation

🔬   𝐍𝐞𝐰 𝐏𝐚𝐩𝐞𝐫 𝐏𝐮𝐛𝐥𝐢𝐬𝐡𝐞𝐝 𝐨𝐧 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐯𝐞 𝐈𝐧-𝐋𝐢𝐧𝐞 𝐃𝐞𝐭𝐞𝐜𝐭𝐢𝐨𝐧 𝐨𝐟 𝐈𝐠𝐆 𝐀𝐠𝐠𝐫𝐞𝐠𝐚𝐭𝐞𝐬 𝐢𝐧 𝐁𝐢𝐨𝐩𝐫𝐨𝐜𝐜𝐞𝐬𝐢𝐧𝐠 🔬 We are excited to share groundbreaking advancements in biopharmaceutical production with the release of a new scientific article on the in-line detection of IgG aggregates during affinity chromatography using our sensor technology. 𝐀𝐛𝐬𝐭𝐫𝐚𝐜𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬: Monoclonal antibodies (mAbs), particularly Immunoglobulin G (IgG), are pivotal in treating a wide range of diseases but are prone to aggregation during production. Detecting and removing these aggregates has traditionally been a time-consuming and laborious process. Our novel fiber optical in-line sensor, based on localized surface plasmon resonance (LSPR), addresses these challenges by enabling real-time, specific detection of IgG and its aggregates. 𝐊𝐞𝐲 𝐅𝐢𝐧𝐝𝐢𝐧𝐠𝐬: * 𝐒𝐞𝐧𝐬𝐢𝐭𝐢𝐯𝐞 𝐃𝐞𝐭𝐞𝐜𝐭𝐢𝐨𝐧: Our sensor can identify aggregate concentrations below 1% and detect differences as small as 0.3% between samples. * 𝐏𝐫𝐨𝐜𝐞𝐬𝐬 𝐄𝐟𝐟𝐢𝐜𝐢𝐞𝐧𝐜𝐲: This technology reduces the need for off-line analysis, facilitating greater automation and process intensification. * 𝐕𝐞𝐫𝐬𝐚𝐭𝐢𝐥𝐞 𝐈𝐧𝐭𝐞𝐠𝐫𝐚𝐭𝐢𝐨𝐧: Successfully tested across multiple chromatography systems, from lab scale to pilot scale. This study was a collaborative effort between Linköping University, Cytiva Sweden and ArgusEye and we give a big thanks to all of the authors: Thuy Tran, Robert Gustavsson Lindberg, Erik Martinsson, Filip Bergqvist, Andreas Axen, Ingemar Lundström, Carl-Fredrik Mandenius, and Daniel Aili for your hard work! 🔗 Read the Full Study Here: https://lnkd.in/djUqCNKv At ArgusEye, we are committed to advancing biopharma technology, ensuring efficient and high-quality therapeutic antibody production. #biopharma #mAbs #chromatography #inlinedetection #LSPR #realtime #ArgusEye

🔎 Discover the future of bioprocess monitoring with Auga™! Swipe to see how Auga™ compares to traditional methods like ELISA and ProA-UV when set-up in an at-line format. The key difference is that Auga™ offers real-time in-line/on-line capabilities, providing accurate quantification from upstream to downstream! Learn more below👇

🚀 We are thrilled to announce that ArgusEye has been awarded the prestigious Bio-X Accelerate grant! 🎉 This significant support will propel our innovation to new heights. With the added resources: * We will accelerate the development of an in-line probe for the upstream process of biologics. * Our advancements will include sensor chips designed for continuous measurements throughout the entire bioprocess cycle. * This addition to our product portfolio will significantly enhance ArgusEye's offering, enabling comprehensive in-line data coverage across the entire bioprocess chain. This acceleration aligns perfectly with our mission: transforming bioprocessing through real-time data. With this injection of resources, we are one step closer to revolutionizing how bioprocessing is done, ensuring more efficient and effective outcomes in the industry.   We thank STUNS Life science for selecting us and extend our heartfelt congratulations to our fellow winners: Strike Pharma AB, Rarity Bioscience , Readily Diagnostics, and Phenaros Pharmaceuticals.    The goals of the Bio-X Accelerate program are to fast-track innovation in the health and life science industries, and we are honored to be part of this transformative initiative. The kick-off is set for this autumn, and you can join us during the pitch event here: https://lnkd.in/diurc_gd   #Innovation #Bioprocessing #RealTimeData #BioXAccelerate #Healthcare #LifeSciences #ArgusEye

✨Meet Jennifer, our fantastic thesis student who will soon be joining the ArgusEye team!🌟 Learn more about her studies, experiences, and future plans.👇 Jennifer Karlsson #ThesisWork #ArgusEye #NewTalent #Innovation #applications

🔎 Discover the future of bioprocess monitoring with Auga™! Swipe to see how Auga™ compares to traditional methods like ELISA and ProA-UV when set-up in an at-line format. The key difference is that Auga™ offers real-time in-line/on-line capabilities, providing accurate quantification from upstream to downstream! Learn more below👇

Exciting times ahead!🚀 The success on the West Coast continues - we're excited to announce that we're taking the next step in our journey by focusing on the East Coast!🇺🇸 We're now setting our sights on Boston and New York, with several exciting demos over ten days with some of the world's largest pharmaceutical players. Working with highly innovative international players provides us with a unique opportunity to continue growing and evolving.🌐 There’s still an opportunity to meet us this fall, don’t hesitate to reach out!🌟 #Expansion #Innovation #EastCoast #GlobalGrowth #Arguseye #Augaone #Scaleup #Teamwork Erik Martinsson Nathalie Elsässer

What are some of the first applications of the Auga platform?🌟 CEO Dr. Erik Martinsson answers in the video below! Learn more about the first product in the Auga platform AugaOne here: https://lnkd.in/dSvAwxYN #ArgusEye #AugaPlatform #applications #BiopharmaInnovation #RealTimeData #DrugDevelopment #Innovation